QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prakash, P. Articles by Krinsky, N. I. Search for Related Content PubMed PubMed Citation Articles by Prakash, P. Articles by Krinsky, N. I.

---

Articles

In Vitro Inhibition of Proliferation of Estrogen-Dependent and Estrogen-Independent Human Breast Cancer Cells Treated with Carotenoids or Retinoids¹

Pankaj Prakash^*2, Robert M. Russell and Norman I. Krinsky^*,

^* Department of Biochemistry, School of Medicine and the Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111-1837

²To whom correspondence should be addressed at Silico Insights, Incorporated, 400 W. Cummings Park, Suite 6475, Woburn, MA 01801. E-mail: pankaj{at}silicoinsights.com.

Both estrogen-receptor (ER) positive MCF-7 and ER-negative Hs578T and MDA-MB-231 human breast cancer cells were treated with carotenoids (ß-carotene, canthaxanthin and lycopene) and retinoids (all-trans-, 9-cis- and 13-cis-retinoic acid and all-trans-retinol). Among carotenoids, ß-carotene significantly reduced the growth of MCF-7 and Hs578T cells, and lycopene inhibited the growth of MCF-7 and MDA-MB-231 cells. Canthaxanthin did not affect the proliferation of any of the three cell lines. All-trans- and 9-cis-retinoic acid significantly reduced the growth of both MCF-7 and Hs578T cells, whereas 13-cis-retinoic acid and all-trans-retinol had a significant effect only on MCF-7 cells. MCF-7 and Hs578T cells treated with all-trans-retinoic acid (all-t-RA) were further studied for the mechanism behind growth inhibition. Retinoic acid receptors and (RAR, ) in MCF-7 cells and RAR, ß and in Hs578T cells were not induced by all-t-RA treatment at either the protein or mRNA level. Hs578T cells treated with all-t-RA had significantly more cells in the G0/G1 stage of the cell cycle, but the same was not observed for MCF-7 cells. All-t-RA induced a dose-dependent cell death in MCF-7 cells, which may be a necrotic phenomenon. These results demonstrate that ER status is an important, although not essential factor for breast cancer cell response to carotenoid and retinoid treatments, and the mode of action of all-t-RA in MCF-7 and Hs578T cells is not through the induction of RAR. Other mechanistic pathways that are either followed by or concomitant with growth inhibition are possible.

KEY WORDS: • ß-carotene • retinoic acid • breast cancer cells • cell cycle • retinoic acid receptors

This article has been cited by other articles:

				C. L. Rock, L. Natarajan, M. Pu, C. A. Thomson, S. W. Flatt, B. J. Caan, E. B. Gold, W. K. Al-Delaimy, V. A. Newman, R. A. Hajek, et al. Longitudinal Biological Exposure to Carotenoids Is Associated with Breast Cancer-Free Survival in the Women's Healthy Eating and Living Study Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 486 - 494. [Abstract] [Full Text] [PDF]

				H. D. Sesso, J. E. Buring, S. M. Zhang, E. P. Norkus, and J. M. Gaziano Dietary and Plasma Lycopene and the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1074 - 1081. [Abstract] [Full Text] [PDF]

				A. Ben-Dor, M. Steiner, L. Gheber, M. Danilenko, N. Dubi, K. Linnewiel, A. Zick, Y. Sharoni, and J. Levy Carotenoids activate the antioxidant response element transcription system Mol. Cancer Ther., January 1, 2005; 4(1): 177 - 186. [Abstract] [Full Text] [PDF]

				B. P. Chew and J. S. Park Carotenoid Action on the Immune Response J. Nutr., January 1, 2004; 134(1): 257S - 261. [Abstract] [Full Text] [PDF]

				A. L. Sabichi, M. R. Modiano, J. J. Lee, Y.-M. Peng, M.-J. Xu, H. Villar, W. S. Dalton, and S. M. Lippman Breast Tissue Accumulation of Retinamides in a Randomized Short-term Study of Fenretinide Clin. Cancer Res., July 1, 2003; 9(7): 2400 - 2405. [Abstract] [Full Text] [PDF]